EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities

Added 25 days ago (17.05.2021)
Authors: Yedier-Bayram, O., Gokbayrak, B., Aksu, A. C., Cavga, A. D., Kayabolen, A., Kala, E. Y., Karabiyik, G., Gunsay, R., Morova, T., Uyulur, F., Lack, N. A., Onder, T. T., Bagci-Onder, T.
Source: bioRxiv
Read article